Evidence map›Paper›PMID 20376198›Full record

ReviewJournal of cardiovascular translational research2010

Gender dimorphisms in progenitor and stem cell function in cardiovascular disease.

Jeremy L Herrmann, Aaron M Abarbanell, Brent R Weil, Mariuxi C Manukyan, Jeffrey A Poynter, Yue Wang, Arthur C Coffey, Daniel R Meldrum

Abstract readReview
In one paragraph

Review in Journal of cardiovascular translational research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Sex differences in cancer mechanisms.Biology of sex differences · 2020
    Review
  8. Gender, hormone therapy, and HIV: what should cardiologists know?Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2019
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jeremy L HerrmannDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
Aaron M Abarbanell
Brent R Weil
Mariuxi C Manukyan
Jeffrey A Poynter
Yue Wang
Arthur C Coffey
Daniel R Meldrum
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineIndiana University · USMethodist Hospital · US

Funding

TNRF1 Signaling Resistance in Ischemic Human Female MyocardiumR01HL085595 · NHLBI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MELDRUM, DANIEL R · 2007 to 2010
$1.8M
Progenitor cell pretreatment against acute surgical I/RR01GM070628 · NIGMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MELDRUM, DANIEL R · 2004 to 2008
$1.5M
IL-18 Signaling in Mesenchymal Stem Cells: Function and Surgial ProtectionF32HL092718 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI ABARBANELL, AARON · 2008 to 2009
$103k
Neonatal Stem Cells: Unique Traits in Paracine Signaling and CardioprotectionF32HL092719 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI HERRMANN, JEREMY · 2008 to 2009
$101k
Sex differences in TNFR2 signaling mechanisms following acute surgical ischemiaF32HL093987 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI WEIL, BRENT RICHARD · 2009 to 2009
$50k
NHLBI NIH HHS F32 HL092718NHLBI NIH HHS F32 HL092719NHLBI NIH HHS F32 HL093987NHLBI NIH HHS R01 HL085595NIGMS NIH HHS R01 GM070628
6 · The paper itself

Abstract

Differences in cardiovascular disease outcomes between men and women have long been recognized and attributed, in part, to gender and sex steroids. Gender dimorphisms also exist with respect to the roles of progenitor and stem cells in post-ischemic myocardial and endothelial repair and regeneration. Understanding how these cells are influenced by donor gender and the recipient hormonal milieu may enable researchers to further account for the gender-related disparities in clinical outcomes as well as utilize the beneficial effects of these hormones to optimize transplanted cell function and survival. This review discusses (1) the cardiovascular effects of sex steroids (specifically estradiol and testosterone); (2) the therapeutic potentials of endothelial progenitor cells, mesenchymal stem cells, and embryonic stem cells; and (3) the direct effect of sex steroids on these cell types.

Indexed as

Mesenchymal Stem Cell TransplantationAnimalsCell DifferentiationCell ProliferationCell SurvivalEmbryonic Stem CellsEndothelial CellsEstradiolFemaleGonadal Steroid HormonesHumansMaleMesenchymal Stem CellsMyocardial IschemiaMyocardiumRegenerationEstradiolGonadal Steroid HormonesTestosteroneCardiovascular DiseaseGender DifferencesProgenitor CellsSex SteroidsStem Cell Therapy

Identifiers

PMID20376198
PMCPMC2850109
OpenAlexW2030042559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.